CellCarta
Highly Engaged Employees
Healthcare Services · Canada · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
201 Av Du President-Kennedy Suite 3900, ...Phone Number
(514) 360-3600Website
www.cellcarta.comRevenue
$105.8 MillionIndustry
About CellCarta
CellCarta is a global Contract Research Organization (CRO) specializing in immune monitoring, genomics, proteomics, histopathology, and regulatory support to enhance precision medicine. They offer a comprehensive range of clinical trial services, including early and late phase trials, companion diagnostics development, and sample logistics. Their clients include top pharmaceutical companies and emerging biotechs seeking reliable, regulatory-ready data and high-touch scientific collaboration throughout the therapeutic development journey. With a focus on complex biomarker expertise and integrated multi-modal capabilities, CellCarta supports the full spectrum of biomarker discovery and clinical trial execution.Explore more
SIC Code 80,807NAICS Code 62,621Show moreCellCarta Org Chart
Compare Similar Companies to CellCarta
Compare insights from companies similar to CellCarta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CellCarta
$105.8M
501-1,000
Private
-
2002
MS
Marcus SilvaChief Marketing Officer Head of Strategic Partnerships
$11.9M
51-200
Public
$150.5M
2016
JO
Joseph O'ConnellExecutive VP, Clinical Development & Medical Affairs
CellCarta Tech Stack
A closer look at the technologies used by CellCarta
Top Healthcare Services Companies
See more top companies
Frequently Asked Questions Regarding CellCarta
Sign Up For FreeTo access detailed company insights
CellCarta is a global Contract Research Organization (CRO) specializing in immune monitoring, genomics, proteomics, histopathology, and regulatory support to enhance precision medicine. They offer a comprehensive range of clinical trial services, including early and late phase trials, companion diagnostics development, and sample logistics. Their c... Read More